| The future of neuro-oncology. | |
| | |
MedLine Citation:
|
PMID: 7766373 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Treatment options for patients with malignant primary and metastatic lesions to the brain are limited and offer little therapeutic benefit. Despite the use of conventional therapy survival of patients is measured in weeks and months. The use of gene therapy with ganciclovir administration and immunotherapy using targeted protein toxins are two experimental approaches to improving this poor prognosis through regional therapy. |
| | |
Authors:
|
H L DeVroom |
Related Documents
:
|
8333343 - Preirradiation osmotic blood-brain barrier disruption plus combination chemotherapy in ... 17560683 - Routine screening by brain magnetic resonance imaging decreased the brain metastasis ra... 23352733 - Outcomes of fertility-sparing surgery for women of reproductive age with figo stage ic ... |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Critical care nursing clinics of North America Volume: 7 ISSN: 0899-5885 ISO Abbreviation: Crit Care Nurs Clin North Am Publication Date: 1995 Mar |
Date Detail:
|
Created Date: 1995-07-06 Completed Date: 1995-07-06 Revised Date: 2005-11-16 |
Medline Journal Info:
|
Nlm Unique ID: 8912620 Medline TA: Crit Care Nurs Clin North Am Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 179-83 Citation Subset: N |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Brain Neoplasms
/
therapy* Forecasting Humans Medical Oncology / methods*, trends Neurology / methods*, trends |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Neurologic involvement of systemic cancer.
Next Document: Evaluation of the advanced practice nurse role in acute and specialty care.